Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BIONNASDAQ:CODX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIONBio Nitrogen Hldgs$0.00$0.00▼$0.01N/AN/A158,122 shsN/ACODXCo-Diagnostics$0.25+7.5%$0.34$0.23▼$2.23$8.36M0.84226,771 shs509,057 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics0.00%-18.77%-33.83%-60.02%-78.15%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIONBio Nitrogen HldgsN/AN/AN/AN/AN/AN/AN/AN/ACODXCo-Diagnostics3.9463 of 5 stars3.54.00.04.41.10.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIONBio Nitrogen Hldgs 0.00N/AN/AN/ACODXCo-Diagnostics 3.00Buy$5.502,108.84% UpsideCurrent Analyst Ratings BreakdownLatest KIBO, BION, NZI, and CODX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025CODXCo-DiagnosticsD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.003/28/2025CODXCo-DiagnosticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$1.50 ➝ $1.00(Data available from 5/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIONBio Nitrogen HldgsN/AN/AN/AN/AN/AN/ACODXCo-Diagnostics$3.71M2.25N/AN/A$2.81 per share0.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIONBio Nitrogen HldgsN/AN/A0.00N/AN/AN/AN/AN/AN/ACODXCo-Diagnostics-$35.33M-$1.17N/AN/AN/A-563.93%-54.94%-49.28%8/14/2025 (Estimated)Latest KIBO, BION, NZI, and CODX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025CODXCo-Diagnostics-$0.33-$0.24+$0.09-$0.24$0.38 million$0.05 million3/27/2025Q4 2024CODXCo-Diagnostics-$0.34-$0.36-$0.02-$0.36$0.38 million$0.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIONBio Nitrogen HldgsN/AN/AN/AN/AN/ACODXCo-DiagnosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBIONBio Nitrogen HldgsN/AN/AN/ACODXCo-DiagnosticsN/A6.926.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIONBio Nitrogen HldgsN/ACODXCo-Diagnostics14.99%Insider OwnershipCompanyInsider OwnershipBIONBio Nitrogen HldgsN/ACODXCo-Diagnostics8.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIONBio Nitrogen HldgsN/AN/AN/ANot OptionableCODXCo-Diagnostics10033.57 million29.98 millionOptionableKIBO, BION, NZI, and CODX HeadlinesRecent News About These CompaniesCo-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock NewsMay 14, 2025 | gurufocus.comCo-Diagnostics, Inc. to Participate in D. Boral Inaugural Global ConferenceMay 14, 2025 | gurufocus.comCo-Diagnostics, Inc. to Participate in D. Boral Inaugural Global ConferenceMay 14, 2025 | globenewswire.comCo-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comCo-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue EstimatesMay 8, 2025 | zacks.comCo-Diagnostics, Inc. Reports First Quarter 2025 Financial ResultsMay 8, 2025 | globenewswire.comExamining the Future: Co-Diagnostics's Earnings OutlookMay 7, 2025 | benzinga.comCo-Diagnostics expands sales agreement, adds Clear Street as agentApril 29, 2025 | uk.investing.comD. Boral Capital Initiates Coverage of Co-Diagnostics (CODX) with Buy RecommendationApril 29, 2025 | msn.comCo-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and WebcastApril 29, 2025 | globenewswire.comAll You Need to Know About CoDiagnostics (CODX) Rating Upgrade to BuyApril 2, 2025 | zacks.comCo-Diagnostics price target lowered to $1 from $1.50 at H.C. WainwrightMarch 30, 2025 | markets.businessinsider.comCo-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South AfricaMarch 27, 2025 | msn.comCo-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue EstimatesMarch 27, 2025 | zacks.comCo-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call TranscriptMarch 27, 2025 | seekingalpha.comCo-Diagnostics, Inc. Reports Full Year 2024 Financial ResultsMarch 27, 2025 | prnewswire.comUncovering Potential: Co-Diagnostics's Earnings PreviewMarch 27, 2025 | benzinga.comCo-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and WebcastMarch 13, 2025 | prnewswire.comCo-Diagnostics wins dismissal of class action lawsuitMarch 7, 2025 | markets.businessinsider.comCo-Diagnostics, Inc. Wins Dismissal of Class Action LawsuitMarch 6, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKIBO, BION, NZI, and CODX Company DescriptionsBio Nitrogen Hldgs OTCMKTS:BIONBioNitrogen Holdings Corp. engages in the manufacture of fertilizers through the conversion of agricultural biomass. It focuses on building turnkey manufacturing facilities to produce urea fertilizer, urea ammonium nitrate, melamine, and diesel exhaust fluid. The company was founded by Mario G. Beruvides on September 16, 1990 and is headquartered in Doral, FL.Co-Diagnostics NASDAQ:CODX$0.25 +0.02 (+7.51%) Closing price 04:00 PM EasternExtended Trading$0.26 +0.01 (+4.42%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft's Outlook Brightens as Analysts Boost Bullish Ratings Palantir Scores First $1 Billion Contract; Is It Priced In? Tesla: Why Analysts Think It Could Jump Another 47% Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and Outlook 3 Dividend Stocks to Get You Through Tariff Volatility Apple Sinks After New 25% Tariff Announcement—What's The Bottom? MarketBeat Week in Review – 05/19 - 05/23 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
